Glenmark Pharmaceuticals competitors

Glenmark Pharmaceuticals Competitors include Clementia Pharmaceuticals, ProtoKinetix, Cryo-Cell International and Synthace.
Add company...
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company. It is the leader in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
Clementia Pharmaceuticals
Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.
ProtoKinetix
ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo.
Cryo-Cell International
Cryo-Cell provides cord blood banking and cord tissue storage.
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
Founding Date
Founding Date
1977
Founding Date
2012
Founding Date
1999
Founding Date
1989
Founding Date
2011
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Mumbai, IN HQ
Locations
Westmount, CA HQ
Newton, US
Locations
Saint Marys, US HQ
Locations
Oldsmar, US HQ
Locations
London, GB HQ
Employees
Employees
7,000
Employees
492% increase
Employees
N/A
Employees
729% increase
Employees
454% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
27.9 m
Valuation ($)
66.3 m
Valuation ($)
N/A
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
3.5 k
Facebook likes
66
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
100
Twitter followers
883
Twitter followers
506

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$25.4m (FY, 2017)
Revenue (est.)
£581 (FY, 2013)
Net income
Net income
N/A
Net income
($57.5m) (FY, 2016)
Net income
N/A
Net income
$2.3m (FY, 2017)
Net income
(£361.6k) (FY, 2013)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 60m (over 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 9.9m (about 1 year ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 92.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 16.2m
For sources of this data, please see the company profileDownload Excel

View company profiles

Clementia Pharmaceuticals
HQ
Westmount, CA
Employees
49↑ 2% increase

Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.

View company
ProtoKinetix
HQ
Saint Marys, US

ProtoKinetix is a bio-technology company that provides medical researchers with a platform for enhancing cell survival and health, both in vitro and in vivo.

View company
Cryo-Cell International
HQ
Oldsmar, US
Employees
72↑ 9% increase

Cryo-Cell provides cord blood banking and cord tissue storage.

View company
Synthace
HQ
London, GB
Employees
45↓ 4% decrease

Synthace produces bio-based chemical products through the application of synthetic biology.

View company